Skip to content
Aperlena

Spain - Pharmaceutical products - Framework agreement for the supply of medicines without competition for the hospitals of the Cantabrian Health Service

Original España - Productos farmacéuticos - Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (principios activos Darunavir/Cobicistat/Emtricitabina/Tenofovir, Darunavir/Cobicistat, Rilpivirina, Paliperidona Palmitato semestral, Paliperidona Palmitato trimestral, Apalutamida, Macitentan, Esketamina Hidrocloruro, Guselkumab)

Awarded Contract award

Key facts

Awarded
Estimated value
€50,548,738
Where
Spain Cantabria
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 2 weeks ago
Notice number
607614-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Awarded
  2. Published

Summary

Machine-generated summary

The Cantabrian Health Service awarded a framework agreement for the supply of medicines without competition for its hospitals, covering nine lots: Symtuza, Rezolsta, Edurant, Byannli, Trevictra, Erleada, Opsumit, Spravato and Tremfya, with active substances including Darunavir/Cobicistat, Rilpivirina, Paliperidona Palmitato, Apalutamida, Macitentan, Esketamina and Guselkumab. The contract was awarded to JANSSEN-CILAG, S.A. for EUR 50,548,737.61. The award date was 2026-07-30.

Description

Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (principios activos Darunavir/Cobicistat/Emtricitabina/Tenofovir, Darunavir/Cobicistat, Rilpivirina, Paliperidona Palmitato semestral, Paliperidona Palmitato trimestral, Apalutamida, Macitentan, Esketamina Hidrocloruro, Guselkumab) Lote 1. Symtuza (Darunavir Etanolato/Cobicistat/Emtricitabina/Tenofovir Alafenamida Fumarato); Lote 2. Rezolsta (Darunavir Etanolato/Cobicistat); Lote 3. Edurant (Rilpivirina); Lote 4. Byannli (Paliperidona Palmitato Semestral); Lote 5. Trevictra (Paliperidona Palmitato Trimestral); Lote 6. Erleada (Apalutamida); Lote 7. Opsumit (Macitentan); Lote 8. Spravato (Esketamina); Lote 9. Tremfya (Guselkumab)

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago

More from this buyer

Full buyer profile

3 open tenders right now

Recent awards

Similar tenders

1

day left

Supply of non-latex surgical gloves

Spain Medical equipment & pharmaceuticals Dirección Gerencia de Mutualia, Mutua Colaboradora con la Se...

€3,318

est. value

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,085,809
9,975 open across Europe right now 356% above sector average
Buyer track record on Aperlena
481 notices tracked · 449 awarded
€61,006,781 in awarded contracts

Never miss a tender like this

886 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language